SIREN : 793904814
IFM is a French company founded 13 years ago, specialized in the sector Recherche-développement en biotechnologie. Based in PARIS (75011), this company of category PME shows in 2024 a revenue of 12.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-07-11
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
Signal structurel : exploitation déficitaire (EBE négatif).
In summary, IFM posts positive profitability over the latest financial year. Its financial structure is solid, with debt well contained relative to its sector.
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12 339 781 € | 23 166 461 € | 9 903 985 € | 9 733 142 € | 13 508 157 € | 17 859 060 € | 20 208 626 € | 15 063 973 € | 10 956 482 € |
| Net income | 393 868 € | 8 400 341 € | -1 531 607 € | 2 225 762 € | 5 062 873 € | 5 912 972 € | 5 773 980 € | 3 103 246 € | 3 828 760 € |
| EBITDA | -3 679 491 € | 5 808 396 € | -2 892 351 € | -660 445 € | 1 745 712 € | 4 495 640 € | 2 227 998 € | 2 189 273 € | 3 534 465 € |
| Net margin | 3.2% | 36.3% | -15.5% | 22.9% | 37.5% | 33.1% | 28.6% | 20.6% | 34.9% |
In 2024, IFM achieves revenue of 12.3 M€. Activity remains stable over the period (CAGR: -2.2%). Significant drop of -47% vs 2023. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -3.7 M€, representing -29.8% of revenue. Warning negative scissor effect: despite revenue change (-47%), EBITDA varies by -163%, reducing margin by 54.9 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 394 k€, i.e. 3.2% of revenue. This profit can be retained or distributed to shareholders.
12 339 781 €
12 339 781 €
-3 679 491 €
-3 367 680 €
393 868 €
-29.8%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. Compared with its sector, this ratio places the company among the best positioned (sector median: 14.7%). Financial autonomy (= Equity / Total assets x 100) reaches 60%. This ratio is more favorable than the sector median (53.9%).
0.02%
60.16%
-0.12%
-0.38
45.5%
In 2024, the debt ratio of IFM (0.0%) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of IFM (60.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
The liquidity ratio (= Current assets / Current liabilities) stands at 5.80. This ratio is more favorable than the sector median (3.7).
5.8
-10.1
In 2024, the liquidity ratio of IFM (5.80) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 287 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 211 days. The gap of 76 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 145 days of revenue, i.e. 5.0 M€ to permanently finance. Between 2021 and 2024, WCR worsened by 19 days of revenue, signaling an increased financing need.
4 961 949 €
287 j
211 j
0 j
145 j
Indicative estimate only : the number of comparable transactions in this sector is limited (36 transactions). This range of 1 305 623€ to 7 442 090€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 36 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare IFM with other companies in the same sector:
Voir toutes les statistiques du secteur Recherche-développement en biotechnologie
Largest companies by revenue in the sector Recherche-développement en biotechnologie:
Largest companies by revenue in the department Paris:
The revenue of IFM in 2024 is 12.3 M€.
Yes, IFM generated a net profit of 394 k€ in 2024.
The headquarters of IFM is located in PARIS (75011), in the department Paris.
The tax return of IFM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
IFM operates in the sector Recherche-développement en biotechnologie (NAF code 72.11Z). See the 'Sector positioning' section above to compare the company with its competitors.